We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
United Oil & Gas Plc | LSE:UOG | London | Ordinary Share | GB00BYX0MB92 | ORD GBP0.00001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.005 | -2.56% | 0.19 | 0.18 | 0.20 | 0.195 | 0.19 | 0.20 | 2,295,120 | 15:42:31 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Crude Petroleum & Natural Gs | 15.83M | 2.35M | 0.0036 | 0.53 | 1.25M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/8/2019 13:04 | With FTSE down 440pts+ in the last week - it's not a bad time to have our shares suspended! | fbrj | |
05/8/2019 08:01 | Yup quoting an RNS, I am such a bad guy. LOL. | ileeman | |
05/8/2019 08:00 | No, happy that others know what you are like. | soulsauce | |
05/8/2019 07:57 | Good that we agree. Must have been the 100p remark that calmed you down. | ileeman | |
05/8/2019 07:54 | Thanks for making my point - 'pointing out the very obvious' lol. Oh and as suspected you don't have a position. | soulsauce | |
05/8/2019 07:44 | @Soul Dont know why you are getting upset I am only pointing out the VERY obvious, I dont need to hold to have an opinion. Just think it is strange figures getting thrown about when the only thing that really matters to the market is what price the equity is. If you get upset over me just quoting the RNS then you are over exposed. And saying BP is involved so it must be good is silly, as an example look at SRSP. 100p on relist happy now? | ileeman | |
05/8/2019 06:01 | So are we saying that the placing will most likely be announced at the same time or maybe even after the prospectus if the CPR is not expected until then? | bountyhunter | |
05/8/2019 05:59 | Not just the CPR, a whole AIM admission document. If they use the same independent CPR that Rockhopper did, then that would considerably shorten the time. Plus if it's a full Aim admission doc, won't we also need a CPR on the new licences, and potentially a CPR update/refresher on the other assets that were included in the AIM admission document 6 months ago. When they moved from the main market to AIM, they announced the move on 31 Jan, and the AIM admission prospectus was dated on 22 Feb, and announced 26 Feb. Maybe the work is more extensive this time, but I would have hoped (that word again) that it could be issued by the end of this month. edit - not sure whether this will be linked, but last year's interim results were issued on 18 September | spangle93 | |
04/8/2019 21:20 | I would think having done months of due diligence they will already have much of the information but Spangle is the one to ask about that. | soulsauce | |
04/8/2019 21:04 | Do we now when that will be? | bountyhunter | |
04/8/2019 20:58 | Bounty I am sure they will wait until after the Cprs are published. | soulsauce | |
04/8/2019 20:41 | The share prediction is certainly a tricky one in this case. Yes the relisting will be several weeks at the earliest as they have said 19Q4 but I was wondering at what point they will do the placing. | bountyhunter | |
04/8/2019 17:11 | Yes probably a matter of weeks before resisting bounty. I am still reckoning on some share base reorganisation so may be I ought to have put 18p rather than 6p. | soulsauce | |
04/8/2019 16:57 | that's what I thought I was doing :-$ any idea when we might hear news on the raise, presumably before the relisting doc is published or is it anyone's guess? | bountyhunter | |
04/8/2019 16:39 | Not a bad strategy Spangle, a win win 😊 | soulsauce | |
04/8/2019 16:32 | Souls - I was basing my low price on iLeeman's reasoning - I'm hoping yer man will blarney his way to getting insti investors to part with their funds at a higher price than that which it's suspended at, but not expecting it. I'm hoping Owls will get promoted, .... Some of the AIM listed big oil and gas producers have very low PER, like DGO or JSE. You'd like to think there would be a re-rating of these at some stage. Others produce 2,000 bopd (TXP, CASP), but do these have earning after corporates and tax have eaten into the operational profit? On the flip side, it's a proven play, rather than the chance to invest in a greenfield development that carries more risk, and like you say, the most interesting (and positive) riddle is why BP would put up funds. I can see their rationale in the win:win deal that SQZ negotiated, and I know they're very active in Egypt, but, well, why would they? So I've punted low - either to be proven right or pleasantly surprised ;-) | spangle93 | |
04/8/2019 14:24 | I agree and I see my guess as on the conservative side, although the price of the raise will have some impact of course and that is yet to be seen. | bountyhunter | |
04/8/2019 14:15 | It wasn't a wild guess. I calculated earnings per share based on the figures from Rockhoppers RNS's for their oil, and applied a PE ratio I thought appropriate and came up with just over 11p. Does anyone know the current average industry PE ratio for a junior AIM listed oil and gas exploration/developm | the manini | |
04/8/2019 13:51 | "Equity placing planned to fund the balance of the Transaction" Surely the price of relist will depend on what price the equity raise is, if it is a discount then it will not go down well but flat or premium raise would go down very well. As I said if the asset is a good as they claim in the RNS then they should have no problem raising at a higher price. | ileeman | |
04/8/2019 12:13 | Yes we need a clean relisting absolutely no later than Q4 with no ifs or buts! However a deal in this case is essential! ;-) | bountyhunter | |
04/8/2019 12:10 | We are all BORIS trained | cpap man | |
04/8/2019 12:07 | At least there is a little bit of optimism there lol! | bountyhunter |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions